Articles tagged "Survival"

2016 American Transplant Congress
Economic Analysis of Survival for Patients Undergoing Kidney Transplant in a Philanthropic Hospital of Sao Paulo, Brazil.
A. Matos,¹ D. Malheiros,² S. Morgado,¹ L. Requiao-Moura,¹ A. Kanamura,³ M. Cendoroglo,³ O. Pavao Santos,³ A. Pacheco-Silva.¹
¹Renal Transplantation Unit, Hospital Israelita Albert Einstein, Sao Paulo, Brazil; ²Health Economy Department, Hospital Israelita Albert Einstein, Sao Paulo, Brazil; ³Management Department, Hospital Israelita Albert Einstein, Sao Paulo, Brazil.
Brazil has one of the most important public programs of transplant in the world. Our hospital is a private philanthropic that has already performed more…
2016 American Transplant Congress
Clinical and Subclinical Cardiac Events After Kidney Transplantation (KTX).
F. Cosio,¹ H. Amer,¹ M. Keddis,² A. Jaffe.³
¹Transplant Center, Mayo Clinic, Rochester, MN; ²Nephrology, Mayo Clinic, Phoenix, AZ; ³Lab Medicine/Pathology, Mayo Clinic, Rochester, MN.
Introduction. Elevated levels of the biomarker cardiac troponin T levels (cTNT) pre- KTX relates to high mortality and CV risk pre and post-KTX. We sought…
2015 American Transplant Congress
Preservation Solution Impacts Short- and Long-Term Survival in Orthotopic Heart Transplant Recipients
C. Lewis,¹ S. Jayarajan,¹ S. Taghavi,¹ S. Kadakia,¹ V. Ambur,¹ A. Shiose,³ G. Wheatley,³ L. Kaiser,² T. Guy,³ Y. Toyoda.³
¹Department of Surgery, Temple University Hospital, Philadelphia, PA; ²Division of Thoracic Surgery, Temple University Hospital, Philadelphia, PA; ³Division of Cardiovascular Surgery, Temple University Hospital, Philadelphia, PA.
Objectives: To examine the effect of three commonly used preservation solutions on short- and long-term survival after orthotopic heart transplantation (OHT) using a large national…
2015 American Transplant Congress
Glomerular Disease (GD) After Kidney Transplant (KTx): Etiologies, Risk Factors and Consequences
F. Cosio,¹ A. Grupper,¹ E. Lorenz,¹ M. Alexander,² L. Cornell.²
¹Nephrology, Mayo Clinic, Rochester, MN; ²Pathology, Mayo Clinic, Rochester, MN.
Introduction. Recipients who develop KTx GD may have reduced function and higher risk of graft loss. Using protocol and clinical biopsies we sought to determine…
2015 American Transplant Congress
Survival of Patients With Peripheral Vascular Disease on Kidney Waitlist and After Transplantation: An Analysis of the United State Renal Data System
A. Brar,¹ D. Stefanov,³ R. Jindal,² N. Sumrani,⁴ D. John,⁴ F. Tedla,¹ M. Salifu.¹
¹Department of Medicine, SUNY Downstate Medical Center, Brooklyn, NY; ²Department of Surgery, Walter Reed National Military Medical Center, Uniformed Services University of Health Sciences, Bethesda, MD; ³Division of Research, SUNY Downstate School of Medicine, Brooklyn, NY; ⁴Department of Surgery, SUNY Downstate Medical Center, Brooklyn, NY.
Introduction: There is lack of information whether waitlisted dialysis patients with peripheral vascular disease (PVD) benefit from kidney transplantation.Methods: We used a cohort of USRDS…
2015 American Transplant Congress
Clinical Outcomes of Kidney Transplan Recipients After Sirolimus Or Everolimus Conversion. Experience in a Single Center
L. Mesa, E. Manzi, M. Valderrama, J. Posada, J. Schweineberg, C. Duran, G. Echeverri, J. Villegas, O. Serrano, L. Caicedo.
Transplant Unit, Fundación Valle del Lili, Cali, Colombia.
Introduction. The use of m_TOR inhibitors sirolimus (SRL) and everolimus (EVL), in kidney transplant recipients (KTR) is an alternative immunosuppressive therapy to reduce or withdrawal…
2015 American Transplant Congress
Cancer Mortality Among Recipients of Solid Organ Transplant in Ontario
S. Acuna,^1,2,3 K. Fernandes,⁴ C. Daly,^2,3 L. Hicks,³ R. Sutradhar,^1,4 S. Kim,^1,4 N. Baxter.^1,2,3,4
¹Institute of Health Policy, Management and Education, University of Toronto, Toronto, ON, Canada; ²Department of Surgery, St. Michael's Hospital, Toronto, ON, Canada; ³Keenan Research Centre, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, ON, Canada; ⁴Institute for Clinical Evaluative Sciences, Toronto, ON, Canada.
Purpose: Solid organ transplantation recipients (SOTR) have a higher risk of some cancers than the general population, but are also at high risk of mortality…
2015 American Transplant Congress
Examining Long-Term Survivors in Combined Heart-Lung Transplantation
S. Kadakia,¹ S. Jayarajan,¹ S. Taghavi,¹ V. Ambur,¹ C. Lewis,¹ A. Shiose,² G. Wheatley III,² L. Kaiser,³ T. Guy,² Y. Toyoda.²
¹Department of Surgery, Temple University Hospital, Philadelphia, PA; ²Division of Cardiovascular Surgery, Temple University Hospital, Philadelphia, PA; ³Division of Thoracic Surgery, Temple University Hospital, Philadelphia, PA.
The goal of this study was to determine variables associated with mortality in combined heart-lung transplantation (HLT).The United Network for Organ Sharing (UNOS) database was…
2015 American Transplant Congress
Impact of Elevated BMI on Allograft Outcomes: A Competing Risks Regression Analysis
A. Naik, A. Sakhuja, M. Samaniego, P. Shrivastava, D. Cibrik.
Section of Nephrology, University of Michigan, Ann Arbor, MI.
INTRODUCTION: Extremes of BMI has been associated with an increased risk of death censored allograft failure. Traditionally the KM product limit estimate has been used…
2015 American Transplant Congress
De Novo Once-Daily Tacrolimus in Liver Transplantation: Long-Term Outcomes of a Single Center Cohort of 150 Patients
M. Gastaca, A. Valdivieso, J. Bustamante, P. Ruiz, J. Fernandez, A. Ventoso, M. Testillano, I. Palomares, P. Salvador, M. Prieto, A. Matarranz, M. Suarez, J. Ortiz de Urbina.
Liver Transplantation Unit, Cruces University Hospital. University of the Basque Country, Bilbao, Vizcaya, Spain.
Purpose: To describe the long-term safety and efficacy profile of de novo once-daily tacrolimus (Tac QD) in orthotopic liver transplantation (OLT)Patients and methods: A retrospective…